Evaluation of the Xpert MTB/XDR test for detection of isoniazid, fluoroquinolones, and second-line injectable drugs resistance to Mycobacterium tuberculosis-Anhui Province, China. [PDF]
Zhang R +11 more
europepmc +1 more source
Tuberculous spondylodiscitis with atypical presentation: A diagnostic challenge: Case report and review of literature. [PDF]
Ghoullam G +6 more
europepmc +1 more source
Isoniazid-resistant TB and associated factors in Ethiopia. [PDF]
Moga S +8 more
europepmc +1 more source
Computational guided identification of novel anti-mycobacterial agent proved by in-vitro and in-vivo validation. [PDF]
Shalaby MM +4 more
europepmc +1 more source
Old Pathogens-New Patient Types: Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated? [PDF]
Melchio M +10 more
europepmc +1 more source
An Outbreak of Isoniazid-Resistant Tuberculosis in a School Originating from Household Transmission - Guigang City, Guangxi Zhuang Autonomous Region, China, November 2024. [PDF]
Xu D +8 more
europepmc +1 more source
Management of latent TB infection: a national survey of French physicians. [PDF]
Dournon N +12 more
europepmc +1 more source
Adverse pregnancy outcomes and complications of tuberculosis in pregnant women. [PDF]
Su Y, Kong X, Chen Z, Wang X, Lu S.
europepmc +1 more source
A comparative study using Xpert MTB/RIF and culture methods evaluates MassARRAY technology for rapid detection of <i>Mycobacterium tuberculosis</i> and drug resistance. [PDF]
Wu S +5 more
europepmc +1 more source

